Retinitis Pigmentosa comprises a large group of inherited vision disorders that cause progressive degeneration of the retina, the light sensitive membrane that coats the inside of the eyes. Peripheral (or side) vision gradually decreases and eventually is lost in most cases. Central vision is usually preserved until late in these conditions.
DelveInsight’s, “Retinitis Pigmentosa Pipeline Insights, 2021,” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Retinitis pigmentosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for free sample report: https://www.delveinsight.com/sample-request/retinitis-pigmentosa-pipeline-insight
Some of Retinitis Pigmentosa Companies are:
DelveInsight’s Retinitis Pigmentosa report covers around 30+ products under different phases of clinical development like:
Some of Retinitis Pigmentosa Drugs are:
Table of Contents:
Introduction
Executive Summary
Retinitis pigmentosa: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
Retinitis pigmentosa – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Retinitis pigmentosa Collaboration Deals
AAV8-RPGR/BIIB112: Nightstar Therapeutics/Biogen
Mid Stage Products (Phase II)
ReN 003: ReNeuron
jCell: jCyte
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
Risuteganib: Allegro Ophthalmics
NPI 001: Nacuity Pharmaceuticals
Pre-clinical and Discovery Stage Products
LCA10 program: Editas Medicine
SB623: SanBio
Inactive Products
Retinitis pigmentosa Key Companies
Retinitis pigmentosa Key Products
Retinitis pigmentosa- Unmet Needs
Retinitis pigmentosa- Market Drivers and Barriers
Retinitis pigmentosa- Future Perspectives and Conclusion
Retinitis pigmentosa Analyst Views
Appendix
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/retinitis-pigmentosa-pipeline-insight